Neos Therapeutics, Inc. (NEOS): Price and Financial Metrics


Neos Therapeutics, Inc. (NEOS): $1.15

-0.03 (-2.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NEOS Stock Summary

  • NEOS has a market capitalization of $57,220,154 -- more than approximately merely 10.36% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for NEOS is -2.77 -- better than just 3.04% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -5.48 for Neos Therapeutics Inc; that's greater than it is for merely 2.92% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Neos Therapeutics Inc are TELA, CRY, ADMS, ADMA, and VAPO.
  • NEOS's SEC filings can be seen here. And to visit Neos Therapeutics Inc's official web site, go to www.neostx.com.

NEOS Stock Price Chart Interactive Chart >

Price chart for NEOS

NEOS Price/Volume Stats

Current price $1.15 52-week high $1.68
Prev. close $1.18 52-week low $0.45
Day low $1.06 Volume 15,005,900
Day high $1.18 Avg. volume 7,441,074
50-day MA $0.91 Dividend yield N/A
200-day MA $0.73 Market Cap 57.22M

Neos Therapeutics, Inc. (NEOS) Company Bio


Neos Therapeutics develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The company was founded in 2008 and is based in Grand Prairie, Texas.


NEOS Latest News Stream


Event/Time News Detail
Loading, please wait...

NEOS Latest Social Stream


Loading social stream, please wait...

View Full NEOS Social Stream

Latest NEOS News From Around the Web

Below are the latest news stories about Neos Therapeutics Inc that investors may wish to consider to help them evaluate NEOS as an investment opportunity.

The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Veric...

Benzinga | March 19, 2021

Vote Against The Merger Of Neos Therapeutics Inc $NEOS

Headquartered in Grand Prairie, TEXAS, Neos Therapeutics Inc (NEOS) is a pharmaceutical company, develops, manufactures, and commercializes products for the

StockMarketRevolution | March 18, 2021

NEOS Stock: Neos Therapeutics Climbs on Merger Hopes - CNA Finance

NEOS stock is screaming for the top as investors await the results of a special meeting surrounding a potential merger with AYTU.

CNA Finance | March 18, 2021

Why Did Aytu Biosciences Gap Up Today? Technical Levels To Watch

Aytu Biosciences Inc. (NASDAQ: AYTU ) shares gapped up Thursday morning. The price jump is speculatively from the meetings the company is having about the proposed merger with Neos Therapeutics Inc. (NASDAQ: NEOS ). Aytu Short Term Chart Analysis: The 5-minute chart above shows the stock has built higher lows throughout the week and last up to a resistance level of $10. The stock broke out of the resistance level and is now falling back to support. The stock could test the potential support and find a … Full story available on Benzinga.com

Benzinga | March 18, 2021

30 Stocks Moving in Thursday's Pre-Market Session

Gainers Neos Therapeutics, Inc. (NASDAQ: NEOS) shares rose 58.6% to $1.84 in pre-market trading. Upstart Holdings, Inc. (NASDAQ: UPST) rose 42.6% to $86.71 …

Benzinga | March 18, 2021

Read More 'NEOS' Stories Here

NEOS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 106.50%
3-year -76.29%
5-year -82.36%
YTD 84.09%
2020 -58.63%
2019 -8.48%
2018 -83.82%
2017 74.36%
2016 -59.15%

Continue Researching NEOS

Here are a few links from around the web to help you further your research on Neos Therapeutics Inc's stock as an investment opportunity:

Neos Therapeutics Inc (NEOS) Stock Price | Nasdaq
Neos Therapeutics Inc (NEOS) Stock Quote, History and News - Yahoo Finance
Neos Therapeutics Inc (NEOS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9032 seconds.